5 stocks being talked about on ASX – RAP, AHZ, LPD, CLA and CCZ

stocks talked about

RESAPP HEALTH LIMITED (ASX: RAP) – It is under the health care sector and as a leading digital company, from the Australian Prospective Paediatric Clinical study, it has announced positive top-line results. As reported by the company down by 57% compared from the previous year in 2017 of $204,317, it posted a revenue in 2018 from ordinary activities of $87,007. It also suffered a loss after tax which is 35% down from previous year of $6.53 million as a result there was no dividend declared by the board in the current or previous reporting period. Comparing better to the previous year loss of $1.53 per share, the disappointing performance led to the loss per share of $0.99. At the end of the year ResApp had cash and cash equivalents of $3.39 million. The stock was trading at $0.230, with the negative EPS of -0.009 AUD.

ADMEDUS LTD (ASX: AHZ) – To secure $8.76 million before costs in additional investment, a placement and share purchase plan was taken up recently. Record revenue of $6.6 million for the June quarter was delivered by the company and this showcases improvement in performance. The group is now signing many agreements for distribution, including the one lately signed in Italy. The loss has increased from previous year of $8,828,576 as at Dec 31, 2017 to $11,542,095 as at June 30, 2018. With the negative EPS of -0.048 AUD, the stock was last trading flat at $0.135, the company is however, under the suspended status. The company has not declared and has no plans to pay any interim or final dividends during the year like the previous corresponding year.

LEPIDICO LTD (ASX: LPD) – At the Youanmi Lepidolite Project located in the Murchison District in Western Australia Lepidico Ltd has started drilling three priority lepidolite targets indicating increase in production. Generated from its farms in agreement over the Lemare Spodumene project in Quebec, the company undertook a strategic review of exploration results. Lepidico successfully produced battery grade lithium carbonate, during the March 2018 quarter. As at June 30, 2018 the company has cash position of $4.9 million with no debt. The stock was trading at a market price of $0.020 and with a daily price change of -$0.005 and a percentage change of -20% as at September 03, 2018. The stock has however, undergone a performance change of 117.19% over the past 12 months. At an issue price of $0.019 per share with one new option for every two shares subscribed are issued, the offer is being made for entitlement issue of one share for every seven shares held by shareholders.

CELSIUS RESOURCES LIMITED (ASX: CLA) – The company has politically stable and safe location as Nambia which is mining friendly. Led by the looming electric vehicle and battery storage revolutions, there is a strong future demand for cobalt, which is also driving the prices higher. Celsius Resources Limited has provided the latest updates at its 95% owned Opuwo Cobalt Project to illustrate the consistent nature of the mineralization at Opuwo, and that the existing JORC-compliant Mineral Resource has excellent potential for significant expansion. Despite the shift to lower cobalt batteries during this time frame, market forecasts are that the use of cobalt in batteries will more than triple between 2017 and 2026. The cash and cash equivalents in hand as at June 30, 2018 is of $12.4 million. The stock was trading flat at a market price of $0.100 September 03, 2018. The stock has however, undergone a performance change of 117.39% over the past 12 months.

CASTILLO COPPER LIMITED (ASX: CCZ) – With results up to 10.25% Cu, 6.04% Zn & 32.5g/t Ag recorded, the first five drill-holes had excellent assays. The company has cash and cash equivalents at the end of quarter June 30, 2018 of $1.710 million. Focused mostly on the NSW projects, there were significant operational activities during the period. Across the tenure with all landowners, CCZ has now successfully negotiated land access and compensation agreements. The stock was trading at a market price of $0.046 and with a daily price change of -$0.003 and a percentage change of -6.122% as at September 3, 2018. The stock has undergone a performance change of 11.36% over the past 12 months. CCZ has a negative EPS of -0.005 AUD with no dividend history in the past few years.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report